11 May 2018
Dr Alex Artyomenko

Dr. Alex Artyomenko currently serves as the Head of Rare Disease and RWE Research at Ergomed. Initially trained as a cardiologist, Alex managed acute care for ICU patients prior to joining the research field. Alex has nearly 20 years of clinical research experience, and has been involved in developing and implementing study designs and operational strategies for global studies and programs, involving many types of observational studies and therapeutic indications. Alex’s passion is research and development of new treatments for rare diseases, with a patient-centric approach to research. He is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), focusing on improving standards for observational research, and helping companies to strengthen the value of their products through Real-World Evidence.